Characteristics of Patients Dying with Cancer in Developed Countries–Reply
JAMA
Authors
Carl R. Blankart, Ph.D.; Ezekiel J. Emanuel, M.D., Ph.D.; Justin E. Bekelman, M.D.
CHIBE Experts
Research Areas
You might also be interested in...
View all publications-
Using machine learning to unveil relevant predictors of adherence to recommended health-protective behaviors during the COVID-19 pandemic in Denmark
International Association of Applied PsychologyJune 8, 2024 -
A randomised trial of "Fresh Start" text messaging to improve return to care in people living with HIV who missed appointments in South Africa
AIDSMay 29, 2024 -
Participant perspectives on incentives for TB preventative therapy adherence and reduced alcohol use: A qualitative study
PLOS Global Public HealthApril 24, 2024 -
Mobile Delivery of COVID-19 Vaccines Improved Uptake in Rural Sierra Leone
NatureMarch 13, 2024 -
How Do Surrogates Make Treatment Decisions for Patients With Dementia: An Experimental Survey Study
Health EconomicsFebruary 15, 2024 -
Provider and Female Client Economic Costs of Integrated Sexual and Reproductive Health and HIV Services in Zimbabwe
PLoS OneFebruary 12, 2024 -
Experiences and Perceptions of Conditional Cash Incentive Provision and Cessation Among People With HIV for Care Engagement: A Qualitative Study
BMC Public HealthFebruary 7, 2024 -
Evaluation of Four Interventions Using Behavioural Economics Insights To Increase Demand for Voluntary Medical Male Circumcision in South Africa Through the MoyaApp: A Quasi-Experimental Study
medRxivJanuary 20, 2024 -
Default Palliative Care Consultation for Seriously Ill Hospitalized Patients: A Pragmatic Cluster Randomized Trial
JAMA NetworkJanuary 16, 2024 -
Clinician Perspectives on Virtual Specialty Palliative Care for Patients With Advanced Illnesses
Journal of Palliative MedicineJanuary 10, 2024 -
Financial Incentives for Reduced Alcohol Use and Increased Isoniazid Adherence During Tuberculosis Preventive Therapy Among People With HIV in Uganda: An Open-Label, Factorial Randomised Controlled Trial
The Lancet Global HealthDecember 1, 2023 -
Adapting and Scaling a Proven Diabetes Prevention Program Across 11 Worksites in India: The INDIA-WORKS Trial
Implementation Science CommunicationsNovember 13, 2023